NASDAQ:PRTO

Proteon Therapeutics Stock Forecast

etoro logo Buy PRTO
*Your capital is at risk
$27.58
+0.244 (+0.89%)
At Close: Jul 10, 2026
AI Analysis AI Analysis of PRTO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PRTO to Watchlist?
Some Reasons Why To Add PRTO:
  • Bullish trend confirmed on both short and long timeframes
  • Lower volatility than the market (beta 0.73)
  • +9.0% YTD performance
PDF

Green day on Friday for Proteon Therapeutics Inc.
(Updated on Jul 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jul 07, 2026 Gain 0.31%

The Proteon Therapeutics Inc. stock price gained 0.89% on the last trading day (Friday, 10th Jul 2026), rising from $27.34 to $27.58. During the last trading day the stock fluctuated 0.0740% from a day low at $27.58 to a day high of $27.60. The price has been going up and down for this period, and there has been a 0.18% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 405 more shares were traded than the day before. In total, 407 shares were bought and sold for approximately $11.22 thousand.

The stock lies in the middle of a narrow and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.52% during the next 3 months and, with a 90% probability hold a price between $27.73 and $29.07 at the end of this 3-month period.

PRTO Signals & Forecast

The Proteon Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $27.52 and $27.58. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Proteon Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 15, 2026, and so far it has fallen -2.06%. Further fall is indicated until a new bottom pivot has been found. The stock had a Golden Star Signal on Tuesday, June 30, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Tuesday, June 30, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Sell
Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Monday, June 15, 2026 and based on theory for this formation the price should fall by -6.59% to $25.76 within 7 trading days (Thursday, June 25, 2026) since signal was issued.

Support, Risk & Stop-loss for Proteon Therapeutics Inc. stock

Proteon Therapeutics Inc. finds support from accumulated volume at $27.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0204 between high and low, or 0.0740%. For the last week the stock has had daily average volatility of 0.460%.

Our recommended stop-loss: $26.45 (-4.08%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 17 days ago.)

Trading Expectations (PRTO) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Proteon Therapeutics Inc. to open at $27.59, and during the day (based on 14 day Average True Range), to move between $27.44 and $27.72, which gives a possible trading interval of +/-$0.271 (+/-0.99%) up or down from last closing price. If Proteon Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 0.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $27.61 (0.11%) than the support at $27.45 (0.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Proteon Therapeutics Inc. stock A Buy?

Proteon Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.010 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $27.59 ( 0.0247%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PRTO Performance

Trading levels for PRTO

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 27.61 0.0986%
R2 27.60 0.0704%
R1 27.59 0.0529%
Price 27.58
S1 27.58 -0.0036%
S2 27.57 -0.0211%
S3 27.57 -0.0493%

Accumulated Volume Support & Resistance Levels

Level Price
R3 27.94 1.31%
R2 27.86 1.02%
R1 27.61 0.110%
Price 27.58
S1 27.45 -0.470%
S2 27.23 -1.28%
S3 27.20 -1.37%

FAQ

What is the symbol for Proteon Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Proteon Therapeutics Inc. is PRTO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Proteon Therapeutics Inc. Stock?
Proteon Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Proteon Therapeutics Inc. Stock?
Proteon Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Proteon Therapeutics Inc. Stock.

What's the current price of Proteon Therapeutics Inc. Stock?
As of the end of day on the Jul 10, 2026, the price of an Proteon Therapeutics Inc. (PRTO) share was $27.58.

What is the 52-week high and low for Proteon Therapeutics Inc. Stock?
The 52-week high for Proteon Therapeutics Inc. Stock is $28.16 and the 52-week low is $24.79.

What is the market capitalization of Proteon Therapeutics Inc. Stock?
As of the Jul 10, 2026, the market capitalization of Proteon Therapeutics Inc. is 15.853M.
Click to get the best stock tips daily for free!
ABOUT PROTEON THERAPEUTICS INC.
Proteon Therapeutics
Proteon Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular diseases. It develops vonapanitase, a recombinant human elastase, which is in two Phase III clinical trials in patients with chronic kidney disease undergoing surgical creation of a radiocephalic arteriovenous fistula for hemodialysis; has completed a Phase I/II clinical trials ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE